InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by EVNIN ANTHONY B, Director. Director active across 2 companies, notably Cantel Medical CORP. In total, 5 reports have been recorded. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€29,85846,378 shares@ €0.643863.4% of flow
Common Stock
SEC:0001140361-22-023338:0·
€8,6253,061 shares@ €2.817818.3% of flow
Common Stock
SEC:0001140361-21-020643:0·
€8,6253,061 shares@ €2.8178100.0% of flow
Common Stock
SEC:0001140361-21-020643·
€800,76112,132 shares@ €66.004100.0% of flow
Common Stock, par value $.10 per share
SEC:0001104659-21-075850·
€800,76112,132 shares@ €66.00450.0% of flow
Common Stock, par value $.10 per share
SEC:0001104659-21-075850:0·
5 of 5 declarations
About EVNIN ANTHONY B
Anthony B. Evnin is a Board Member at Cantel Medical Corp and Infinity Pharmaceuticals, Inc. In this role, he actively participates in board discussions and contributes to strategic decision-making. His experience in the medical sector allows him to provide valuable insights on risk management and the company's growth. He is committed to promoting effective governance and ensuring the company's sustainability.
